Concepedia
Statistics
Publications
41
Citations
1.6K
H-Index
22
Active since
2011
Affiliations
Moffitt Cancer Center(Current)
Cleveland Clinic
The University of Texas MD Anderson Cancer Center
Dana-Farber Cancer Institute
Cornell University
Najla Al Ali is an author at Moffitt Cancer Center specializing in medicine, myelodysplastic syndromes, and hematology.
Publications per year
2011–2024
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
Mrinal M. Patnaik, Eric Padron, Rebecca R. Laborde et al. · Leukemia · 2013 · 219 citations
Medicine, Hematology, Oncology +16
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation
Andrew Kuykendall, Savan Shah, Chetasi Talati et al. · Annals of Hematology · 2017 · 129 citations
Medicine, Hematology, Pharmacotherapy +8
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
Amer M. Zeidan, Mikkael A. Sekeres, Guillermo Garcia‐Manero et al. · Leukemia · 2015 · 88 citations · Full text
Medicine, Hematology, Pharmacotherapy +13
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes
Anthony M. Hunter, Rami S. Komrokji, Seongseok Yun et al. · Blood Advances · 2021 · 74 citations · Full text
Medicine, Molecular Genetics, Molecular Medicine +16
Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)
David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Blood · 2019 · 73 citations
Medicine, Oncology, Pharmacotherapy +16
1–5 of 41